The DOI matches its Crossref record.
Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis.
Open accessAbstract
By intrasplenic immunization we raised a rat mAb (mAb V1q; IgG2a, kappa) with a potent neutralizing activity against natural mouse TNF (1 microgram/ml mAb V1q/100 U/ml TNF). mAb V1q was used to study the role of endogenous TNF in experimental peritonitis induced by sublethal cecal ligation and puncture. mAb V1q persisted for over 5 days in the serum of mice injected with 100 micrograms of the antibody and, therefore, proved useful for in vivo experiments. As little as 20 micrograms mAb V1q/mouse prevented lethal shock of the animals by 400 micrograms LPS/mouse. In sublethal cecal ligation and puncture i.p. injection of mAb V1q directly and up to 8 h after induction of experimental peritonitis lead to death of the animals within 1 to 3 days. The lethal effect of mAb V1q was compensated by injection of recombinant mouse TNF. Similar mAb V1q effects as in immunocompetent mice were shown in severe combined immune deficiency mice deficient of mature functional B and T cells. Taken together, these data suggest that during the early phase of peritonitis endogenous TNF may stimulate nonlymphoid cells such as granulocytes, macrophages, platelets, and fibroblasts to ingest bacteria and to localize inflammation, respectively. These beneficial effects of TNF may determine survival. Thus, our data may have implications for the therapeutic management of a beginning peritonitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Malaviya, R., Ikeda, T., Ross, E., & Abraham, S. N. (1996) · Nature · doi:10.1038/381077a0 · Cited by 1,123
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
Critical protective role of mast cells in a model of acute septic peritonitis
Echtenacher, B., Männel, D. N., & Hültner, L. (1996) · Nature · doi:10.1038/381075a0 · Cited by 926
Self-citationAnimal Models of sepsis: setting the stage
Buras, J. A., Holzmann, B., & Sitkovsky, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1854 · Cited by 843
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
Dejager, L., Pinheiro, I., Dejonckheere, E., & Libert, C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.01.001 · Cited by 784
Tumor necrosis factor in the heart
Meldrum, D. R. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.3.r577 · Cited by 746
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Self-citationGlauser, M. P., Zanetti, G., Baumgartner, J.-D., & Cohen, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91452-z · Cited by 716
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists
Scallon, B., Cai, A., Solowski, N., Rosenberg, A., Song, X.-Y., Shealy, D., & Wagner, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.418 · Cited by 672
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
Duprez, L., Takahashi, N., Van Hauwermeiren, F., Vandendriessche, B., Goossens, V., Vanden Berghe, T., Declercq, W., Libert, C., Cauwels, A., & Vandenabeele, P. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.020 · Cited by 583
Animal models of sepsis and sepsis-induced kidney injury
Doi, K., Leelahavanichkul, A., Yuen, P. S. T., & Star, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39421 · Cited by 580
Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., & Wagner, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.91 · Cited by 574
Self-citationBoes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C., & Chen, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2381 · Cited by 554
Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Gröne, H.-J., Kurschus, F. C., Schmidt, A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18704 · Cited by 524
(2008) · Arthritis & Rheumatism · doi:10.1002/art.23363 · Cited by 505
Cytokines in Inflammatory Bowel Disease
Rogler, G., & Andus, T. (1998) · World Journal of Surgery · doi:10.1007/s002689900401 · Cited by 484
Anti-inflammatory cytokine profile and mortality in febrile patients
VANDISSEL, J., VANLANGEVELDE, P., WESTENDORP, R., KWAPPENBERG, K., & FROLICH, M. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80013-6 · Cited by 482
Rietschel, E. T., Brade, H., Holst, O., Brade, L., Müller-Loennies, S., Mamat, U., Zähringer, U., Beckmann, F., Seydel, U., Brandenburg, K., et al. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80186-0_3 · Cited by 469
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 442
Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock
Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Häcker, H., Heeg, K., & Wagner, H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270712 · Cited by 416
The disconnect between animal models of sepsis and human sepsis
Rittirsch, D., Hoesel, L. M., & Ward, P. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806542 · Cited by 406
Joosten, L. A. B., Helsen, M. M. A., van de Loo, F. A. J., & van den Berg, W. B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390513 · Cited by 400
Supajatura, V., Ushio, H., Nakao, A., Okumura, K., Ra, C., & Ogawa, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2250 · Cited by 370
Balance of inflammatory cytokines related to severity and mortality of murine sepsis
Walley, K. R., Lukacs, N. W., Standiford, T. J., Strieter, R. M., & Kunkel, S. L. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4733-4738.1996 · Cited by 366
Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., et al. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00003 · Cited by 361
Gibot, S., Kolopp-Sarda, M.-N., Béné, M.-C., Bollaert, P.-E., Lozniewski, A., Mory, F., Levy, B., & Faure, G. C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040708 · Cited by 361
Ronco, C., Tetta, C., Mariano, F., Wratten, M. L., Bonello, M., Bordoni, V., Cardona, X., Inguaggiato, P., Pilotto, L., D’Intini, V., et al. (2003) · Artificial Organs · doi:10.1046/j.1525-1594.2003.07289.x · Cited by 356
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease
Lue, H., Kleemann, R., Calandra, T., Roger, T., & Bernhagen, J. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01560-5 · Cited by 349
Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
Ananieva, O., Darragh, J., Johansen, C., Carr, J. M., McIlrath, J., Park, J. M., Wingate, A., Monk, C. E., Toth, R., Santos, S. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1644 · Cited by 326
CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS
van der Poll, T., & van Deventer, S. J. H. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70083-0 · Cited by 323
KOJOUHAROFF, G., HANS, W., OBERMEIER, F., MA¨NNEL, D. N., ANDUS, T., SCHO¨LMERICH, J., GROSS, V, & FALK, W. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1997.291-ce1184.x · Cited by 317
Self-citationOBERMEIER, F., KOJOUHAROFF, G., HANS, W., SCHÖLMERICH, J., GROSS, V, & FALK, W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00878.x · Cited by 317
Self-citationThe potential biological and clinical significance of the soluble tumor necrosis factor receptors
Aderka, D. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00026-3 · Cited by 285
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Immunomodulatory therapies in sepsis
Kox, W. J., Volk, T., Kox, S. N., & Volk, H. D. (2000) · Intensive Care Medicine · doi:10.1007/s001340051129 · Cited by 256
Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke
Martin-Villalba, A., Hahne, M., Kleber, S., Vogel, J., Falk, W., Schenkel, J., & Krammer, P. H. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400882 · Cited by 209
Self-citationEnhancement of experimental metastasis by tumor necrosis factor.
Orosz, P., Echtenacher, B., Falk, W., Rüschoff, J., Weber, D., & Männel, D. N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1391 · Cited by 198
“9 [5-56]) had no influence on the number of lung metastases on day 11, 0.”
BackgroundSelf-citationNeural regulators of innate immune responses and inflammation
Pavlov, V. A., & Tracey, K. J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4102-3 · Cited by 174
Goren, I., Müller, E., Schiefelbein, D., Christen, U., Pfeilschifter, J., Mühl, H., & Frank, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700842 · Cited by 151
“To this end, we injected a monoclonal antibody against murine TNFa (V1q) (Echtenacher et al., 1990) into wounded ob/ob mice.”
MethodBiologic Control of Injury and Inflammation: Much More than Too Little or Too Late
Guirao, X., & Lowry, S. F. (1996) · World Journal of Surgery · doi:10.1007/s002689900069 · Cited by 102
Chaudhry, M. Z., Wang, J. H., Blankson, S., & Redmond, H. P. (2008) · Surgical Infections · doi:10.1089/sur.2006.077 · Cited by 56
Exercise alters serum pneumoprotein concentrations
Nanson, C. J., Burgess, J. L., Robin, M., & Bernard, A. M. (2001) · Respiration Physiology · doi:10.1016/s0034-5687(01)00251-1 · Cited by 30
Therapy with antibody to tumor necrosis factor in sepsis
Pennington, J. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.supplement_2.s515 · Cited by 26
“may result in worsened outcome [41].”
Metadata
- Authors
- Echtenacher, B., Falk, W., Männel, D. N., & Krammer, P. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-12-01
- Volume
- 145
- Issue
- 11
- Pages
- 3762-3766
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2168699998
- Cited by
- 433
- References
- 0
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.